XML 27 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Interim Consolidated Statement of Cash Flows (USD $)
In Thousands
3 Months Ended9 Months Ended183 Months Ended
Sep. 30, 2011
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Cash flows from (used in): Operating Activities    
Net (loss)/income$ (3,144)$ 1,176$ (1,240)$ (107,479)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation and amortization   1,404
Non-cash Cadherin Biomedical Inc. litigation   1,187
Unrealized loss/(gain) on derivative2,221(3,683)(2,498)(432)
Amortization of deferred lease inducements   (412)
Unrealized foreign exchange loss (3) 42
Loss on impairment of capital assets   386
Non-cash severance   168
Stock-based compensation - consultants2977 852
Stock-based compensation - employees1291292,43910,095
Acquired in-process research and development   13,094
Changes in operating assets and liabilities129(155)26(180)
Net cash used in operating activities(636)(2,459)(1,273)(81,276)
Investing activities    
Purchase of capital assets   (1,440)
Loss on capital assets   115
Cash (pledged) released as collateral   190
Restricted cash   (209)
Proceeds from sale of assets   24
(Purchase) redemption of short-term investments   643
Investment in CBI   (166)
Acquired intellectual property rights   (640)
Net cash used in investing activities   (1,483)
Financing activities    
Conversion of long-term debt to equity   68
Long-term debt repayment   (65)
Capital lease payments   (8)
Issuance of units, net of issue costs 2,5667,19086,443
Registration expense   (465)
Proceeds from convertible note   3,017
Other liability repayments   (87)
Financing expenses   (544)
Security deposits received   35
Proceeds from exercise of stock options   51
Net cash provided by financing activities 2,5667,19088,445
Effect of exchange rate on cash and cash equivalents 120 488
(Decrease) increase in cash and cash equivalents(636)2275,9176,174
Cash and cash equivalents - beginning of period6,8105,947685 
Cash and cash equivalents - end of period$ 6,174$ 6,174$ 6,602$ 6,174